Clinical Trial Update: Transfusion Effects in Myelodysplastic Patients: Limiting Exposure [Phase 4]

View source ↗

Summary

Phase 4 trial on transfusion effects in myelodysplastic syndromes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Sanquin Research & Blood Bank Divisions | Conditions: Myelodysplastic Syndromes | Phase 4 | Status: WITHDRAWN